Schedule of Segment Information |
Selected financial information for the Company’s
operating segments is as follows:
|
|
Three Months Ended
September 30,
|
|
|
Nine Months Ended
September 30,
|
|
|
|
2019 |
|
|
2018 |
|
|
2019 |
|
|
2018 |
|
Net revenues - External |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hospital Operations |
|
$ |
3,920,608 |
|
|
$ |
5,021,543 |
|
|
$ |
13,081,647 |
|
|
$ |
9,755,099 |
|
Clinical Laboratory Operations |
|
|
(34,631 |
) |
|
|
17,569 |
|
|
|
56,169 |
|
|
|
177,890 |
|
|
|
$ |
3,885,977 |
|
|
$ |
5,039,112 |
|
|
$ |
13,137,816 |
|
|
$ |
9,932,989 |
|
(Loss) income from continuing operations before income taxes: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hospital Operations |
|
$ |
(1,769,400 |
) |
|
$ |
(1,294,581 |
) |
|
$ |
(8,946,720 |
) |
|
|
(3,998,943 |
) |
Clinical Laboratory Operations |
|
|
(295,908 |
) |
|
|
(547,041 |
) |
|
|
(701,466 |
) |
|
|
(1,765,395 |
) |
Corporate |
|
|
(640,044 |
) |
|
|
(973,953 |
) |
|
|
(2,626,953 |
) |
|
|
(3,156,646 |
) |
Other income (expense), net |
|
|
(9,422,340 |
) |
|
|
100,171,656 |
|
|
|
(26,064,924 |
) |
|
|
4,955,262 |
|
|
|
$ |
(12,127,692 |
) |
|
$ |
97,356,081 |
|
|
$ |
(38,340,063 |
) |
|
$ |
(3,965,722 |
) |
Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hospital Operations |
|
|
182,832 |
|
|
$ |
39,669 |
|
|
$ |
532,979 |
|
|
$ |
177,386 |
|
Clinical Laboratory Operations |
|
|
10,036 |
|
|
|
112,908 |
|
|
|
69,381 |
|
|
|
625,877 |
|
Corporate |
|
|
7,128 |
|
|
|
248 |
|
|
|
7,458 |
|
|
|
811 |
|
|
|
$ |
199,996 |
|
|
$ |
152,825 |
|
|
$ |
609,818 |
|
|
$ |
804,074 |
|
Capital expenditures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hospital Operations |
|
$ |
7,086 |
|
|
$ |
103,387 |
|
|
$ |
50,801 |
|
|
$ |
103,387 |
|
Clinical Laboratory Operations |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
$ |
7,086 |
|
|
$ |
103,387 |
|
|
$ |
50,801 |
|
|
$ |
103,387 |
|
|
|
As of |
|
|
|
September 30, 2019 |
|
|
December 31, 2018 |
|
Total assets |
|
|
|
|
|
|
|
|
Hospital Operations |
|
$ |
16,831,443 |
|
|
$ |
13,568,933 |
|
Clinical Laboratory Operations |
|
|
356,854 |
|
|
|
271,426 |
|
Corporate |
|
|
1,821,952 |
|
|
|
2,707,416 |
|
Assets of AMSG and HTS classified as held for sale |
|
|
373,121 |
|
|
|
152,171 |
|
Eliminations |
|
|
(2,809,305 |
) |
|
|
(2,500,646 |
) |
|
|
$ |
16,574,065 |
|
|
$ |
14,199,300 |
|
|